To access this element change to forms mode OFF
Grant Award View - GA82103
Tailoring dendritic cell diversity to advance effective immunotherapies
GA ID:
GA82103
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
20-Apr-2020
Publish Date:
11-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jan-2021 to 31-Dec-2025
Value (AUD):
$709,726.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Tailoring dendritic cell diversity to advance effective immunotherapies
Purpose:
Dendritic cells (DCs) constitute the first line of defense against infection and cancer. To achieve this feat, DC have evolved into a sophisticated network of specialized subtypes, although how this diversification process occurs is yet to be fully clarified. We have uncovered a new molecule, termed DC-SCRIPT, which has a key role in establishing the DC network, specialization and function. This offers crucial new clues as to how to manipulate DCs to either boost or dampen the immune system.
GO ID:
GO Title:
Investigator Grants 2020
Internal Reference ID:
GNT1196235
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA